The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2015
Filed:
Mar. 18, 2011
Applicants:
Nancy Yuk-yu Ip, Hong Kong, CN;
Fanny Chui-fun Ip, Hong Kong, CN;
Shengjun Guo, Hong Kong, CN;
Inventors:
Assignee:
Biotechnology Research Corp. Ltd., Hong Kong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 51/00 (2006.01); A61K 31/655 (2006.01); C07J 17/00 (2006.01); A61K 31/015 (2006.01); A61K 31/045 (2006.01); A61K 36/906 (2006.01); A61K 31/05 (2006.01); A61K 31/01 (2006.01); A61K 36/896 (2006.01); A61K 36/27 (2006.01); C07C 43/23 (2006.01); C07C 49/83 (2006.01); C07D 307/79 (2006.01); C07D 307/80 (2006.01); C07D 319/20 (2006.01); C07J 63/00 (2006.01); C07C 59/90 (2006.01); C07C 62/32 (2006.01); C07H 7/04 (2006.01); C07H 7/06 (2006.01);
U.S. Cl.
CPC ...
C07J 17/005 (2013.01); A61K 31/01 (2013.01); A61K 31/015 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 36/27 (2013.01); A61K 36/896 (2013.01); A61K 36/906 (2013.01); C07C 43/23 (2013.01); C07C 49/83 (2013.01); C07C 59/90 (2013.01); C07C 62/32 (2013.01); C07D 307/79 (2013.01); C07D 307/80 (2013.01); C07D 319/20 (2013.01); C07H 7/04 (2013.01); C07H 7/06 (2013.01); C07J 63/008 (2013.01); C07C 2102/10 (2013.01);
Abstract
Isolated compounds fromrefined fractions and compositions containing the compounds are provided by the present invention.refined fractions and the extraction process thereof are also provided by the present invention. The uses of the compounds and therefined fractions for inhibiting the activities of NMDA receptor or amyloid-beta peptide, for improving memory, and for treating neurodegenerative diseases, neuropathological conditions or epilepsy are further provided by the present invention.